Brief: Prosomnus® Announces Completion Of Enrollment In Antwerp University Hospital’S First Line Obstructive Sleep Apnea Treatment Study (Flosat)
21/12/2022 13:02
Prosomnus Inc OSA.O :
* PROSOMNUS® ANNOUNCES COMPLETION OF ENROLLMENT IN ANTWERP
UNIVERSITY HOSPITAL’S FIRST LINE OBSTRUCTIVE SLEEP APNEA
TREATMENT STUDY (FLOSAT)
Source text for Eikon: ID:nGNX3KmwJy
Further company coverage: OSA.O
Recent news on ProSomnus
See all newsBrief: Prosomnus Sleep Technologies Says Co Enters Into Voluntary Chapter 11 Restructuring Process Which Will Take Company Private, Reduce Debt
Prosomnus Inc expected to post a loss of 31 cents a share - Earnings Preview
Prosomnus Inc expected to post a loss of 31 cents a share - Earnings Preview
Brief: Prosomnus Raises $10 Million To Fuel Growth And Optimize Operations
Brief: Updated Clinical Trial Data Indicates Precision Oral Appliance Therapy With Prosomnus Devices Is Non-Inferior To Cpap Therapy For The Treatment Of Moderate To Severe Obstructive Sleep Apnea